Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Parkinson’s drug may work on MS

 

Wednesday 09 October 2013 22:19 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A drug used to treat Parkinson’s disease may provide an effective new therapy for multiple sclerosis, research suggests.

Tests on mice show that the drug, benztropine, stimulates the production of nerve-repairing cells.

MS is an autoimmune disease that causes the body’s own defences to attack myelin, a sheath that protects nerve fibres. Cells called oligodendrocytes are able to repair myelin, but their numbers decline sharply in patients with MS.

Researchers at the Scripps institute in California reported in the journal Nature that benztropine effectively enables the oligodendrocytes to revive.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in